Drug Trial Radar · NCT04259281
A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
Last checked: Nov 20, 2026Latest source record: Jan 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
74
Actual
Start
Feb 24, 2020
Primary completion
Jan 8, 2025
Study completion Jan 8, 2025
Sponsor
- Lead sponsor
- Ultragenyx Pharmaceutical IncIndustry
- Sponsor type
- Industry
- First posted
- Feb 6, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study is to evaluate the safety and tolerability of multiple-ascending doses of GTX-102 administered by intrathecal (IT) injection to participants with Angelman Syndrome (AS).
Conditions
- Angelman Syndrome
Interventions
GTX-102Drug
antisense oligonucleotide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Adverse Events (AEs), Serious AEs (SAEs), Adverse Events of Special Interest (AESIs), AEs Leading to Discontinuation and Severity of AEsTime frame: Up to Day 337
Locations
25 sites in 8 countries. Site status is shown where the registry gives one.
UCLA Medical Center
Los Angeles, California
Rady Children's Hospital
San Diego, California
Rare Disease Research
Atlanta, Georgia
Rush University Medical Center
Chicago, Illinois
Boston Children's Hospital
Boston, Massachusetts
Weill Cornell Medicine
New York, New York
Queensland Children's Hospital
South Brisbane, Australia
Austin Health
Heidelberg, Victoria, Australia
The Royal Children's Hospital
Parkville, Victoria, Australia
MAGIC Clinic Ltd
Calgary, Alberta, Canada
British Columbia Children's Hospital
Vancouver, British Columbia, Canada
Children's Hospital of Western Ontario
London, Ontario, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada
McGill University Health Centre
Montreal, Quebec, Canada
Hopital de la Timone
Marseille, France
AP-HP Hopital Necker-Enfants Malades
Paris, France
Universitatsklinikum Hamburg-Eppendorf
Hamburg, Germany
Universitatsklinikum Leipzig
Leipzig, Saxony, Germany
The Edmond and Lily Safra Children's Hospital
Ramat Gan, Israel
Hospital Sant Joan de Deu
Esplugues de Llobregat, Barcelona, Spain
Hospital Universitari Parc Tauli
Sabadell, Barcelona, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Cambridge University Hospitals
Cambridge, United Kingdom
Great Ormond Street Hospital for Children
London, United Kingdom
Oxford University Hospitals NHS Foundation Trust
Oxford, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.